- Location
1
result for "
injection doses
"-
Novo Nordisk Anticipates Launching Tresiba, Brand Name of Insulin Degludec
Jan 23, 2013The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...
Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies
